# OnCo record idea-prame-tcr-beyond-a02 (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-prame-tcr-beyond-a02/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-prame-tcr-beyond-a02" ;
  schema:name "TCR therapeutics for non-HLA-A*02 patients"@en ;
  schema:description "Today's T-cell-receptor drugs only work for people with one tissue type. Building versions for the other common types would roughly double who can be treated."@en ;
  schema:url <https://onco.cc/ideas/idea-prame-tcr-beyond-a02/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  onco:cancers <https://onco.cc/cancers/melanoma/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/prame/> ;
  onco:drugs <https://onco.cc/drugs/brenetafusp/>, <https://onco.cc/drugs/tebentafusp/> ;
  onco:terms <https://onco.cc/terms/hla-a02-restriction/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-imcgp100-202-n-engl-j-med-2021/>, <https://onco.cc/key-papers/paper-imcgp100-202-n-engl-j-med-2023-update/>, <https://onco.cc/key-papers/paper-tebentafusp-melanoma-cancers-basel-2019/> .